Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 348

1.

Chloroquine potentiates the anti-cancer effect of lidamycin on non-small cell lung cancer cells in vitro.

Liu F, Shang Y, Chen SZ.

Acta Pharmacol Sin. 2014 May;35(5):645-52. doi: 10.1038/aps.2014.3. Epub 2014 Apr 14.

2.

[Synergistic effect and its possible mechanisms of lidamycin in combination with TRAIL in NSCLC].

Yang J, Chen SZ.

Yao Xue Xue Bao. 2010 Oct;45(10):1247-53. Chinese.

PMID:
21348302
3.

[Lidamycin inhibits the proliferation of HERG K+ channel highly expressing cancer cells and shows synergy with anticancer drugs].

Shang BY, Shang Y, Zhen YS, Chen SZ.

Yao Xue Xue Bao. 2011 Nov;46(11):1321-5. Chinese.

PMID:
22260022
4.

Antitumor activity of noscapine in human non-small cell lung cancer xenograft model.

Jackson T, Chougule MB, Ichite N, Patlolla RR, Singh M.

Cancer Chemother Pharmacol. 2008 Dec;63(1):117-26. doi: 10.1007/s00280-008-0720-z. Epub 2008 Mar 13.

PMID:
18338172
5.

[The synergistic effect of lidamycin and rituximab on human B cell lymphoma].

Sun YR, Zhang SH, Shao RG, He HW.

Yao Xue Xue Bao. 2014 Feb;49(2):198-203. Chinese.

PMID:
24761609
6.

Lidamycin up-regulates the expression of thymidine phosphorylase and enhances the effects of capecitabine on the growth and pulmonary metastases of murine breast carcinoma.

Zhang SH, Zhang H, He HW, Li L, Li XQ, Zhang YP, Shao RG.

Cancer Chemother Pharmacol. 2013 Oct;72(4):777-88. doi: 10.1007/s00280-013-2253-3. Epub 2013 Aug 23.

PMID:
23975242
7.

Honokiol exhibits enhanced antitumor effects with chloroquine by inducing cell death and inhibiting autophagy in human non-small cell lung cancer cells.

Lv X, Liu F, Shang Y, Chen SZ.

Oncol Rep. 2015 Sep;34(3):1289-300. doi: 10.3892/or.2015.4091. Epub 2015 Jun 29.

PMID:
26136140
8.
9.

Arsenic trioxide exerts synergistic effects with cisplatin on non-small cell lung cancer cells via apoptosis induction.

Li H, Zhu X, Zhang Y, Xiang J, Chen H.

J Exp Clin Cancer Res. 2009 Aug 8;28:110. doi: 10.1186/1756-9966-28-110.

10.

Effects of insulin-like growth factor binding protein-3 and farnesyltransferase inhibitor SCH66336 on Akt expression and apoptosis in non-small-cell lung cancer cells.

Lee HY, Moon H, Chun KH, Chang YS, Hassan K, Ji L, Lotan R, Khuri FR, Hong WK.

J Natl Cancer Inst. 2004 Oct 20;96(20):1536-48.

PMID:
15494604
11.

Gambogic acid synergistically potentiates cisplatin-induced apoptosis in non-small-cell lung cancer through suppressing NF-κB and MAPK/HO-1 signalling.

Wang LH, Li Y, Yang SN, Wang FY, Hou Y, Cui W, Chen K, Cao Q, Wang S, Zhang TY, Wang ZZ, Xiao W, Yang JY, Wu CF.

Br J Cancer. 2014 Jan 21;110(2):341-52. doi: 10.1038/bjc.2013.752. Epub 2013 Dec 3.

12.

p53 Cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo.

Katiyar SK, Meeran SM, Katiyar N, Akhtar S.

Mol Carcinog. 2009 Jan;48(1):24-37. doi: 10.1002/mc.20453.

PMID:
18459128
13.
14.

A novel combinatorial strategy using Seliciclib(®) and Belinostat(®) for eradication of non-small cell lung cancer via apoptosis induction and BID activation.

Ong PS, Wang L, Chia DM, Seah JY, Kong LR, Thuya WL, Chinnathambi A, Lau JY, Wong AL, Yong WP, Yang D, Ho PC, Sethi G, Goh BC.

Cancer Lett. 2016 Oct 10;381(1):49-57. doi: 10.1016/j.canlet.2016.07.023. Epub 2016 Jul 25.

PMID:
27461583
15.

Metuzumab enhanced chemosensitivity and apoptosis in non-small cell lung carcinoma.

Feng F, Wang B, Sun X, Zhu Y, Tang H, Nan G, Wang L, Wu B, Huhe M, Liu S, Diao T, Hou R, Zhang Y, Zhang Z.

Cancer Biol Ther. 2017 Jan 2;18(1):51-62. doi: 10.1080/15384047.2016.1276126.

16.
17.

The autophagy inhibitor chloroquine overcomes the innate resistance of wild-type EGFR non-small-cell lung cancer cells to erlotinib.

Zou Y, Ling YH, Sironi J, Schwartz EL, Perez-Soler R, Piperdi B.

J Thorac Oncol. 2013 Jun;8(6):693-702. doi: 10.1097/JTO.0b013e31828c7210.

18.

Inhibitory effect of riccardin D on growth of human non-small cell lung cancer: in vitro and in vivo studies.

Xue X, Sun DF, Sun CC, Liu HP, Yue B, Zhao CR, Lou HX, Qu XJ.

Lung Cancer. 2012 Jun;76(3):300-8. doi: 10.1016/j.lungcan.2011.12.013. Epub 2012 Jan 17.

PMID:
22261315
19.

Japonicone A inhibits the growth of non-small cell lung cancer cells via mitochondria-mediated pathways.

Du Y, Gong J, Tian X, Yan X, Guo T, Huang M, Zhang B, Hu X, Liu H, Wang Y, Li J, Li M.

Tumour Biol. 2015 Sep;36(10):7473-82. doi: 10.1007/s13277-015-3439-6. Epub 2015 Apr 25.

PMID:
25908173
20.

15-Deoxy-Delta12,14-prostaglandin J2 enhances docetaxel anti-tumor activity against A549 and H460 non-small-cell lung cancer cell lines and xenograft tumors.

Fulzele SV, Chatterjee A, Shaik MS, Jackson T, Ichite N, Singh M.

Anticancer Drugs. 2007 Jan;18(1):65-78.

PMID:
17159504

Supplemental Content

Support Center